Macrolides for diffuse panbronchiolitis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Yang, Ming ^a   Dong, Bi Rong ^a   Lin, Xiufang ^a   Wu, Hong Mei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; INTERLEUKIN 1; INTERLEUKIN 8; JOSAMYCIN; MACROLIDE; PLACEBO; ROXITHROMYCIN; TROLEANDOMYCIN; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY CONDUCTANCE; ARTERIAL GAS; BRONCHIOLITIS; CLINICAL TRIAL; COCHRANE LIBRARY; DATA SYNTHESIS; DIARRHEA; DIFFUSE PANBRONCHIOLITIS; DRUG EFFECT; DRUG SAFETY; EMBASE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MEDLINE; MYCOSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; QUALITY OF LIFE; RASH; RESIDUAL VOLUME; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIVITY ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; LUNG FUNCTION TEST; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 70349138506     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007716     Document Type: Review

References (27)

1. Azuma A, Kudoh S. Diffuse panbronchiolitis in East Asia. Respirology 2006;11:249-261
2. Chen BZ, Xiang XD, Chen P. A case of diffuse panbronchiolitis. Bulletin of Hunan Medical University 2000;25(6):534.
3. Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest 1989;95:1342-1344
4. Ding K, Liu M-B, Wu JL, Ma H-Q, Fang X-Y, Miao GB, et al. Diffuse panbronchiolitis in China: analysis of 45 cases. Chinese Medical Journal 2007;120:2046-2048 (Pubitemid 350237816)
5. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. American Journal of Respiratory and Critical Care Medicine 1996;154:497-503.
6. Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. International Journal of Antimicrobial Agents 2008;31:12-20.
7. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
8. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
9. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983;83:63-69 (Pubitemid 13172752)
10. Hu H, Liu Y, Cai Z, Chen L. A case of diffuse panbronchiolitis. Chinese Medical Journal 1996;109(12):949-952
11. Izumi T, Doi O, Nobechi A, Homma Y, Kino N, Nakata K, et al. Nation-wide survey of diffuse panbronchiolitis. Annual report on the study of interstitial lung disease in 1982. Grant-in Aid from the Ministry of Health and Welfare of Japan. Tokyo, 1983:3-41.
12. Izumi T. Diffuse panbronchiolitis. Chest 1991;100:596-597
13. Kobayashi H, Takeda H, Sakayori S, Kawakami Y, Otsuka Y, Tamura M, et al. Study on azithromycin in treatment of diffuse panbronchiolitis. Kansenshogaku Zasshi 1995;69:711-722
14. Kudoh S, Kimura H, Uetake M, Hirayama T, Hisaya K, Teratani Y, et al. Clinical effect of low-dose long-term administration of macrolides on diffuse panbronchiolitis. Japanese Journal of Thoracic Disease 1984;254(Suppl):254. (Pubitemid 17141772)
15. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Japanese Journal of Thoracic Diseases 1987;25:632-642 (Pubitemid 17141772)
16. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. American Journal of Respiratory and Critical Care Medicine 1998;157:1829-1832 (Pubitemid 28311266)
17. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008] (available from www.cochrane-handbook.org). Chichester, UK: Wiley-Blackwell, 2008.
18. López-Boado YS, Rubin BK. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Current Opinion in Pharmacology 2008;8:286-291
19. Nakamura H, Fujishima S, Inoue T, Ohkubo Y, Soejima K, Waki Y, et al. Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection. European Respiratory Journal 1999;13:1371-1379 (Pubitemid 29357155)
20. Nakata K, Taguchi Y, Kudoh S. Therapeutic guidelines for DPB. Annual report on the study of diffuse lung disease in 1999. Grant-in aid from the Ministry of Health and Welfare of Japan. Tokyo, 2000:111.
21. Poletti V, Patelli M, Poletti G, Bertanti T, Spiga L. Diffuse panbronchiolitis observed in an Italian. Chest 1990;98:515-516
22. Randhawa P, Hoagland MH, Yousem SA. Diffuse panbronchiolitis in North America. Report of three cases and review of the literature. American Journal of Surgical Pathology 1991;15:43-47
23. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
24. Sandrini A, Balter MS, Chapman KR. Diffuse panbronchiolitis in a Caucasian man in Canada. Canadian Respiratory Journal 2003;10:449-451 (Pubitemid 38195710)
25. Tamaoki J, Takeyama K, Tagaya E, Konno K. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrobial Agents and Chemotherapy 1995;39:1688-1690
26. Yamamoto M, Kudoh S, Ina Y, Tamura A. Clinical efficacy of erythromycin for patients with diffuse panbronchiolitis - a double blind study. Saishin Igaku 1990;45:103-108
27. Yamanaka A, Saiki S, Tamura S, Saito K. Problems in chronic obstructive bronchial diseases, with special reference to diffuse panbronchiolitis. Naika 1969;23:442-451